Revising the hemodynamic criteria for pulmonary hypertension: A perspective from China.

作者信息

Xiong Changming, Yang Beilan

机构信息

Center of Pulmonary Vascular Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China.

出版信息

J Transl Int Med. 2023 Mar 7;11(1):1-3. doi: 10.2478/jtim-2022-0023. eCollection 2023 Mar.

DOI:10.2478/jtim-2022-0023

PMID:37223616

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10202014/

Abstract

摘要

相似文献

[1]

Revising the hemodynamic criteria for pulmonary hypertension: A perspective from China.

J Transl Int Med. 2023-3-7

[2]

Clinical phenotypes, hemodynamic characteristics and prognosis of Chinese patients with systemic sclerosis-associated precapillary pulmonary hypertension: a retrospective study.

Clin Rheumatol. 2022-6

[3]

[Multicenter study of disease attributes in adult patients with pulmonary hypertension].

Zhonghua Yi Xue Za Zhi. 2012-4-24

[4]

Hemodynamic Responses to Provocative Maneuvers during Right Heart Catheterization.

Ann Am Thorac Soc. 2022-12

[5]

Monitoring of Hemodynamics With Right Heart Catheterization in Children With Pulmonary Arterial Hypertension.

J Am Heart Assoc. 2023-4-4

[6]

Impact of the revised hemodynamic definition on the diagnosis of precapillary pulmonary hypertension: a retrospective single-center study in China.

Cardiovasc Diagn Ther. 2021-10

[7]

Assessment of electrocardiographic markers of acute and long-term hemodynamic improvement in patients with pulmonary hypertension.

Ann Noninvasive Electrocardiol. 2020-9

[8]

Plasma irisin levels are associated with hemodynamic and clinical outcome in idiopathic pulmonary arterial hypertension patients.

Intern Emerg Med. 2021-4

[9]

[How do we respond to the newly-revised haemodynamic definitions of pulmonary hypertension].

Zhonghua Yi Xue Za Zhi. 2023-1-10

[10]

ECG Markers of Hemodynamic Improvement in Patients with Pulmonary Hypertension.

Biomed Res Int. 2018-4-10

引用本文的文献

[1]

Adipokines in preeclampsia: disrupted signaling pathways and novel therapeutic strategies.

Eur J Med Res. 2025-8-4

[2]

Histone deacetylase 4: A therapeutic target for cardiovascular diseases (Review).

Int J Mol Med. 2025-10

[3]

MAM kinases: physiological roles, related diseases, and therapeutic perspectives-a systematic review.

Cell Mol Biol Lett. 2025-3-28

[4]

The efficacy, safety and clinical feasibility of a percutaneous atrial septal shunt device for pulmonary arterial hypertension: a single-center cohort study.

Respir Res. 2025-2-23

[5]

Diminazine protects against cardiac aging through the improvement of mitophagy and apoptosis in aging rats induced by D-galactose.

BMC Cardiovasc Disord. 2025-2-18

[6]

Susceptibility of Mitophagy-Deficient Tumors to Ferroptosis Induction by Relieving the Suppression of Lipid Peroxidation.

Adv Sci (Weinh). 2025-2

[7]

Modulating mitochondrial dynamics ameliorates left ventricular dysfunction by suppressing diverse cell death pathways after diabetic cardiomyopathy.

Int J Med Sci. 2024

[8]

2023 Guideline for the management of hypertension in the elderly population in China.

J Geriatr Cardiol. 2024-6-28

[9]

The impact of female sex hormones on cardiovascular disease: from mechanisms to hormone therapy.

J Geriatr Cardiol. 2024-6-28

[10]

Serum ASGR2 level: an efficacy biomarker for balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension.

Front Immunol. 2024

本文引用的文献

[1]

Right Ventricle Remodeling in Chronic Thromboembolic Pulmonary Hypertension.

J Transl Int Med. 2022-7-2

[2]

Impact of the revised hemodynamic definition on the diagnosis of precapillary pulmonary hypertension: a retrospective single-center study in China.

Cardiovasc Diagn Ther. 2021-10

[3]

Mildly Elevated Pulmonary Arterial Pressure Is Associated With a High Risk of Progression to Pulmonary Hypertension and Increased Mortality: A Systematic Review and Meta-Analysis.

J Am Heart Assoc. 2021-4-6

[4]

Impact of the revised haemodynamic definition on the diagnosis of pulmonary hypertension in patients with systemic sclerosis.

Eur Respir J. 2019-8-22

[5]

Proposed new pulmonary hypertension definition: is 4 mm(Hg) worth re-writing medical textbooks?

Eur Respir J. 2019-3-28

[6]

Haemodynamic definitions and updated clinical classification of pulmonary hypertension.

Eur Respir J. 2019-1-24

[7]

Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis.

Eur Respir J. 2018-4-4

[8]

Mild Elevation of Pulmonary Arterial Pressure as a Predictor of Mortality.

Am J Respir Crit Care Med. 2018-2-15

[9]

Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.

Circulation. 2016-3-29

[10]

Definitions and diagnosis of pulmonary hypertension.

J Am Coll Cardiol. 2013-12-24

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Revising the hemodynamic criteria for pulmonary hypertension: A perspective from China.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献